Prostatis Group’s FT Vest Fund of Buffer ETFs BUFR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Buy
50,290
+139
+0.3% +$4.98K 0.43% 51
2026
Q1
$1.69M Sell
50,151
-4,916
-9% -$169K 0.43% 56
2025
Q4
$1.89M Sell
55,067
-16,217
-23% -$548K 0.45% 49
2025
Q3
$2.38M Sell
71,284
-8,517
-11% -$278K 0.6% 46
2025
Q2
$2.54M Sell
79,801
-27,109
-25% -$816K 0.73% 41
2025
Q1
$3.17M Sell
106,910
-11,335
-10% -$346K 1% 28
2024
Q4
$3.6M Sell
118,245
-1,836
-2% -$55.7K 1.05% 24
2024
Q3
$3.59M Buy
120,081
+11,174
+10% +$327K 1.17% 21
2024
Q2
$3.15M Buy
108,907
+11,593
+12% +$327K 1.11% 25
2024
Q1
$2.72M Sell
97,314
-13,551
-12% -$369K 1.03% 29
2023
Q4
$2.95M Sell
110,865
-38,477
-26% -$972K 1.23% 20
2023
Q3
$3.64M Buy
149,342
+51,705
+53% +$1.3M 1.78% 13
2023
Q2
$170K Buy
+97,637
New +$2.34M 0.08% 112

Other funds holding BUFR

Prostatis Group's BUFR Position: Q2 2026 in Review

Prostatis Group increased its FT Vest Fund of Buffer ETFs (BUFR) stake by 0.28% in Q2 2026, buying an estimated $4.98K and bringing the position to 50,290 shares worth $1.84M. The position accounts for 0.43% of the portfolio, ranked #51.

Prostatis Group first reported a position in BUFR in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.64M in Q3 2023. 537 funds tracked by Wall St. Rank hold BUFR as of Q2 2026.

  • Prostatis Group held 50,290 shares of FT Vest Fund of Buffer ETFs worth $1.84M as of Q2 2026.
  • Prostatis Group bought 139 FT Vest Fund of Buffer ETFs shares in Q2 2026, an estimated $4.98K.
  • FT Vest Fund of Buffer ETFs made up 0.43% of Prostatis Group's portfolio in Q2 2026, its #51 holding.
  • Prostatis Group first reported a position in FT Vest Fund of Buffer ETFs in Q2 2023 and has held it in 13 quarters since.
  • Prostatis Group's FT Vest Fund of Buffer ETFs position peaked at $3.64M in Q3 2023.
  • 537 funds tracked by Wall St. Rank held FT Vest Fund of Buffer ETFs as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.